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C E L L  B I O L O G Y
Efficient apoptosis requires feedback amplification of 
upstream apoptotic signals by effector caspase-3 or -7
Scott McComb1*, Pik Ki Chan1*, Anna Guinot1*, Holmfridur Hartmannsdottir1, Silvia Jenni1, 
Maria Pamela Dobay1,2, Jean-Pierre Bourquin1, Beat C. Bornhauser1†
Apoptosis is a complex multi-step process driven by caspase-dependent proteolytic cleavage cascades. Dysregula-
tion of apoptosis promotes tumorigenesis and limits the efficacy of chemotherapy. To assess the complex interac-
tions among caspases during apoptosis, we disrupted caspase-8, -9, -3, -7, or -6 and combinations thereof, using 
CRISPR-based genome editing in living human leukemia cells. While loss of apical initiator caspase-8 or -9 partially 
blocked extrinsic or intrinsic apoptosis, respectively, only combined loss of caspase-3 and -7 fully inhibited both 
apoptotic pathways, with no discernible effect of caspase-6 deficiency alone or in combination. Caspase-3/7 double 
knockout cells exhibited almost complete inhibition of caspase-8 or -9 activation. Furthermore, deletion of caspase-3 
and -7 decreased mitochondrial depolarization and cytochrome c release upon apoptosis activation. Thus, activation 
of effector caspase-3 or -7 sets off explosive feedback amplification of upstream apoptotic events, which is a key 
feature of apoptotic signaling essential for efficient apoptotic cell death.
INTRODUCTION
Programmed cell death is vital to development and maintenance of 
healthy tissues in multicellular animals, and a lack of apoptotic cell 
death is thought to be a key driver of oncogenesis (1). Nonetheless, it 
remains unclear whether apoptosis and its mediators are specifically 
required for cancer cell killing by many chemotherapeutic drugs. In 
addition to their clear functional roles in apoptotic cell death, 
increasing functions for caspases have been identified in biological 
processes as diverse as cell proliferation, differentiation, tissue ho-
meostasis, and immune regulation (2, 3); thus, a better understanding 
of the regulation of caspase signaling may yield valuable insight into 
many broader biological processes.
Originally identified among other family members of Caenorhabditis 
elegans death proteins (4), it is now known that caspases are key 
proteases that activate and mediate apoptotic cell death through a 
cascade of protein cleavage. Apoptotic caspases are hierarchically 
organized into apical caspases (caspase-2, -8, -9, and -10) and effector 
caspases (caspase-3, -7, and -6) (5). Apoptosis can be induced by either 
extrinsic stimulus through death receptors [such as the tumor necrosis 
factor– (TNF) or FAS receptors] that specifically activate caspase-8 
or intrinsic stimulus (such as expression of BCL2 family BH3-only 
proteins BIM or puma) that leads to mitochondrial depolarization 
and activation of caspase-9 (6, 7).
Most models of caspase activation present a hierarchical and linear 
proteolytic cascade, wherein upstream caspases directly cleave effec-
tor caspases that subsequently mediate destruction of the cell through 
direct cleavage of a broad range of substrates (8, 9), and activation 
of downstream death mediators such as caspase-activated deoxyribo-
nuclease (10). In addition to models of hierarchical caspase activation, 
a number of reports have shown that effector caspases may feedback 
on caspase-8 to promote extrinsic apoptosis (11–14) and caspase-9, 
BID, and other BCL2 family members to promote intrinsic apoptosis 
(8, 15, 16). Despite many studies, the difficulty of specifically inacti-
vating caspases has confounded analyses of the specific roles of indi-
vidual effector caspases in apoptosis within an intact human cell.
It is generally believed that effector caspase-3 and -7 are func-
tionally redundant in the activation of apoptosis (17), with the contri-
bution of caspase-6 remaining unclear. Caspase-3 and -7 can be 
individually removed from certain mouse strains with no overt pheno-
type, but caspase-3/7 double-knockout animals cannot survive 
because of fatally disorganized heart development, although mouse 
embryonic fibroblasts derived from mouse embryonic tissue show 
profound resistance to apoptotic cell death not seen in single knockouts 
(16). Despite their functional redundancy, a number of publications 
have indicated some differences in substrate specificity and function 
between caspase-3 and -7 (18, 19); thus, the individual contribution 
of effector caspases to apoptotic activation remains unclear. Despite 
their central role in mediating apoptosis, mutations or deletions of 
caspase-3 and -7 seem only to be relatively rarely detected in tumor 
tissue (20), potentially supporting a view that redundancy and genomic 
segregation of effector caspases may limit the risk of inactivation 
through mutation in cancer cells.
Here, we have undertaken a systematic analysis of the individual 
and combined roles of effector caspase-3, -7, and -6 in chemotherapy- 
induced cell death within human leukemic cell lines. Using CRISPR- 
Cas9 gene targeting, we have specifically disrupted the effector caspase 
genes alone or in all possible combinations. We demonstrate that 
caspase-3 and -7 indeed do show complete redundancy in activating 
apoptosis in response to both extrinsic and intrinsic apoptosis triggers, 
with no apparent role for caspase-6. Furthermore, the absence of both 
caspase-3 and -7 leads to defective activation of upstream caspase-8 and -9 
and a decrease of mitochondria membrane depolarization with delayed 
cytochrome c release, underlining the role of effector caspase feedback 
in activating the apoptotic cascade at different levels.
RESULTS
Caspase-8 and -9 are both activated by extrinsic and intrinsic 
apoptotic stimuli
To investigate the activation of initiator caspases during apoptosis, 
leukemia cells were treated with selective extrinsic or intrinsic 
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ap optotic stimuli. To activate extrinsic apoptosis, we treated NALM6 
leukemia cells with a combination of TNF and Birinapant (Bir/TNF), 
a small-molecule SMAC mimetic that blocks cellular inhibitor of 
ap optotic proteins. We have previously shown that this combination 
induces cell death that is strictly dependent on the extrinsic caspase-8 
apoptotic pathway in human leukemia cells (21). Following the in-
duction of apoptotic cell death by Bir/TNF, we observed coordinated 
appearance of cleaved/activated forms of both caspase-8 and -9 via 
Western blot (Fig. 1A). We also observed progressive loss of the 
inactive full length and appearance of cleaved forms of effector 
caspase-3, -7, and -6, between 16 and 30 hours after treatment 
(Fig. 1A).
To investigate whether we see similar coordinated activation of 
caspase-8 and -9 following stimulation of intrinsic apoptosis, we 
treated these cells with a small-molecule inhibitor of the antiapoptotic 
BCL2 family, ABT263. Similar to our observations with the extrinsic 
apoptotic trigger Bir/TNF, ABT263 treatment resulted in activation of 
both caspase-8 and -9 (Fig. 1B). To confirm the specificity of extrinsic 
(Bir/TNF) or intrinsic (ABT263) apoptotic stimuli, we next used flu-
orescent protein-tagged lentiviral vectors to deliver CRISPR-Cas9 
and targeted single-guide RNAs (sgRNAs) [LentiCRISPR (LC)] to 
generate specific caspase-8 (casp-8−/−) or caspase-9 (casp-9−/−)–deficient 
cell lines derived from three different human leukemia (NALM6, 
658w, or Jurkat; Fig. 1C). Using these cells, we show that caspase-9–
deficient cells show activation of caspase-8 in response to extrinsic 
apoptotic stimulation with Bir/TNF but not to the intrinsic apoptotic 
stimulator ABT263 (Fig. 1D). In contrast, caspase-8–deficient cells 
showed normal caspase-9 activation in response to intrinsic but 
not to extrinsic apoptotic stimulation (Fig. 1E). These results sug-
gest a model wherein either caspase-8 or -9 is required to initiate an 
apoptotic response following extrinsic of intrinsic-specific stimula-
tion, but both pathways become activated following stimulation 
(Fig. 1F).
To examine the downstream effects of loss of caspase-8 or -9 
expression, we stained NALM6 wild-type (WT) or caspase-knockout 
cells with the mitochondrial polarity–dependent dye tetra-methyl 
rhodamine ester (TMRE). We found that casp-9−/− cells retained their 
mitochondrial potential while WT or casp-8−/− cells show complete 
mitochondrial depolarization by 24 hours after ABT263 treatment 
(Fig. 2, A and B).
In contrast, loss of mitochondrial membrane potential following 
Bir/TNF was attenuated in caspase-8–deficient but not WT or casp-9−/− 
cells (Fig. 2, C and D). Agreeing with our TMRE observations, cell 
viability measurements using mitochondrial activity dye (CCK-8) 
demonstrate that caspase-9 deficiency partially protected cells from 
ABT263 but not from Bir/TNF (fig. S1A), whereas caspase-8 defi-
ciency protected cells against Bir/TNF but not ABT263 (fig. S1B). 
Overall, these results are consistent with the canonical understand-
ing of the apoptotic pathways, wherein caspase-8 and -9 are specifically 
required to activate extrinsic and intrinsic apoptosis, respectively. 
Independent of the specific pathway of initiation, however, apoptotic 
leukemia cells show coordinated activation of both caspase-8 and -9, loss 
of mitochondrial membrane potential, and cell death. Unexpectedly, 
caspase-9 deficiency also blocked mitochondria membrane de-
polarization after ABT263 treatment, a process that is generally 
considered to be upstream of caspase-9 activation, supporting a pre-
viously proposed model of functional feedback regulation at the level 
of the mitochondrial membrane (22–24).
Fig. 1. Caspase-8 and -9 are both activated during intrinsic and extrinsic apoptosis. (A and B). Western blot of NALM6 WT cells treated for the indicated time with (A) 
Birinapant (50 nM) and hTNF (10 ng/ml) or (B) with ABT263 (5 M). (C) Western blot of control and CRISPR-knockout caspase-8– or -9–deficient leukemia cells; tubulin 
(Tub) is shown for loading control. (D and E) Activation of caspase-8 and -9, respectively, using caspase-8– or -9–specific FAM-FLICA stains and flow cytometry at indicated 
time points after treatment with (D) Birinapant (50 nM) and hTNF (10 ng/ml) (B + T) or (E) ABT263 (5 M) (ABT) in WT or caspase-8 (C8 ko)– and caspase-9 (C9 ko)–deficient 
cells. (F) Model of apoptotic response activation of caspase-8 and -9 following extrinsic or intrinsic stimuli. Graphs show the mean ± SEM for three repeated experiments 
performed in duplicate.
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Caspase-3 and -7 redundantly activate apoptotic cell death 
with no apparent role for caspase-6 in leukemic cells
To dissect the overlapping roles of the downstream effector caspase pro-
teins in executing apoptotic cell death, we generated effector caspase- 
deficient leukemic cell lines using our multicolor LC approach as 
we have previously described (21, 25). We first transduced the acute 
lymphoblastic leukemia cell lines NALM6, 658w, and Jurkat cells 
with LC–enhanced green fluorescent protein targeting caspase-7, 
LC-mCherry targeting caspase-3, and LC-RFP657 targeting caspase-6 
(fig. S2A). Using single-cell sorting and screening via Western 
blotting, we were able to generate clonal cell lines deficient for 
caspase-3, -7, and -6, or any combination of these proteins de-
rived from three parental leukemia cell lines (Fig. 3, A to C).
To test the effect of specific deficiency in effector caspases on apop-
totic cell death, we treated WT or caspase-knockout cells with either 
extrinsic (Bir/TNF) or intrinsic (ABT263) apoptotic stimuli. Both ex-
trinsic and intrinsic apoptotic stimuli lead to potent killing of all single 
caspase–deficient cell lines, with no apparent dosage effects of single 
loss of any effector caspases (Fig. 3, D to F). In contrast to single- 
knockout lines, NALM6 and 658w cells lacking either caspase-3 and -7 
(casp3/7−/−) or caspase-3, -7, and -6 (casp3,7,6−/−) showed a profound 
resistance to extrinsic and intrinsic apoptosis (Fig. 3, G to I). We con-
firmed similar cell death results using 7-amino-actinomycin D (7-AAD) 
and flow cytometry to examine the loss of cell membrane integrity 
following apoptosis induction in NALM6 WT and casp3/7-deficient 
cells (Fig. 3J).
In the case of extrinsic apoptosis, we note an over 4-log increase in 
median inhibitory concentration (IC50) response to Bir/TNF treat-
ment in NALM6 and 658w cells lacking caspase-3 and -7 (Fig. 3K). In 
contrast to this, Jurkat cells lacking caspase-3 and -7 were resistant to 
ABT but remained sensitive to Bir/TNF induced (Fig. 3K), likely be-
cause of the fact that Jurkat cells undergo necroptotic death upon TNF 
stimulation and inhibition of the extrinsic apoptotic pathway (21). 
We also observed similar induction of cell death following treatment 
of WT, caspase-3/7, or caspase-3/7/6 knockout cells with a Fas ligand, 
which is also known to induce apoptotic and necroptotic cell death 
(fig. S2B) (26). In line with this, necrostatin rescues Jurkat cells from 
Birinapant-induced cell death (fig. S2C). This observation supports 
a model of the necroptosis pathway as a specific alternative to extrinsic 
cell death with no substantial role during intrinsic apoptotic death.
We next confirmed the loss of effector caspase activity in double- 
knockout cells using a fluorogenic substrate assay. As expected, fluoro-
genic caspase-3/7 substrate activity was completely absent in casp3/7−/− 
cells (fig. S2D). Although fluorogenic substrates have been observed 
to be somewhat promiscuously targeted by various caspases, the com-
plete absence of signal in casp3/7−/− cells supports a conclusion that 
effector caspases are functionally redundant in these cells, and caspase-6 
does not sustain any residual DEVD-cleavage activity in the absence 
of caspase-3 and -7. A scatter plot summarizing calculated IC50 re-
sponses for all knockout cell lines tested demonstrates a clear segrega-
tion of cell lines lacking both caspase-3 and -7, with no obvious effect 
for additional loss of caspase-6, with the exception of the necroptotic 
death pathway in Jurkat cells (Fig. 3K).
To confirm whether caspase-3 and -7–deficient cells display long- 
term viability after apoptotic stimulation, we performed washout ex-
periments to remove Bir/TNF or ABT263 from cultures. After 24 hours, 
we observed sustained viability of casp3/7−/− cells, as they were able to 
reach similar cell density compared to untreated WT cells after 1 to 
4 days (fig. S2E). Furthermore, we also performed a colony-forming 
unit assay in methylcellulose to determine the number of viable colonies 
within WT or caspase-3/7−/− cells after 24 to 48 hours of treatment 
with intrinsic or extrinsic apoptotic stimulus. In this case, we ob-
served that the vast majority of cells remain viable in caspase-3/7 
knockout cells after induction of apoptosis (Fig. 3L and fig. S2, F to H). 
Overall, these results show that expression of either caspase-3 or -7 
is adequate for potent activation of apoptosis in response to specific 
Fig. 2. Extrinsic or intrinsic apoptotic inducers differentially trigger mitochondrial depolarization. (A to D) Analysis of mitochondria membrane depolarization 
using TMRE measurements by flow cytometry in WT, caspase-9, and caspase-8 knockout NALM6 cells, upon intrinsic [(A) 5 M ABT263, quantitation in (B)] or extrinsic 
trigger [(C) Birinapant (50 nM), TNFa (10 ng/ml), quantitation in (D)]. Graphs show the mean ± SEM for three repeated experiments performed in duplicate. Student’s t test 
was used for comparison between single time point values as indicated.
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extrinsic or intrinsic apoptotic stimulus, and their combined loss 
prevents the vast majority of apoptotic cell death.
Caspase-3 or -7 is required for full activation of  
apical caspases
We hypothesized that, in the absence of effector caspases, cells stim-
ulated to undergo apoptosis might accumulate high levels of activated 
apical caspases. Thus, we performed a time-course Western blot anal-
ysis to investigate the relative amount of pro- and cleaved caspases at 
various time points after apoptosis induction. In the absence of single 
caspase-3, -7, or -6, we observed no significant change in the ap-
pearance of any cleaved caspases following treatment with a specific 
extrinsic apoptotic stimulus (Fig. 4A). These results agree with our 
observations in cell viability assays, wherein there were no apparent 
dosage effects associated with single loss of caspase-3 or -7 in terms 
of caspase activation or apoptotic cell death.
A B C
D E G
G H I
J K L
Fig. 3. Caspase-3 and -7 are redundantly required for intrinsic or extrinsic apoptosis. (A to C) Western blot of NALM 6 (A), 658w (B), and Jurkat cells (C) with CRISPR- 
based deletion of indicated effector caspases to produce single, double, or triple knockouts. (D to F) Cell viability (in % viability compared to control) analyses using CCK-8 
of single effector caspase knockouts (KOs) in NALM6 (D), 658w (E), and Jurkat (F) upon incubation with Birinapant (50 nM) and hTNF (10 ng/ml) or ABT263 (5 M). (G to I) Cell 
viability analyses (in % viability compared to control) using CCK-8 of indicated double or triple effector caspase knockout in NALM6 (G), 658w (H), and Jurkat (I) upon in-
cubation with Birinapant (50 nM) and hTNF (10 ng/ml) or ABT263 (5 M). (J) Cell viability using 7-AAD of WT or caspase-3/7 double-knockout NALM6 cells in controls and 
upon treatment with Birinapant and hTNF or ABT263 for 24 hours. (K) Dotplot indicating IC50 values for indicated WT and knockout cell lines with values for ABT263 given 
on the y axis and those for Birinapant and hTNF on the x axis. (L) Colony formation assays in Methocult were performed to examine the number of viable cells remaining 
at 24 to 48 hours after treatment with ABT263 or TNF/SM. Cell viability graphs [shown in (D) to (J)] show the mean ± SEM for three repeated experiments performed in 
duplicate. Colony-forming units (CFUs) are the average from three experiments each performed in duplicate.
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In contrast to single knockouts, we observed highly delayed and 
decreased activation of caspase-8 and almost no apparent activation 
of caspase-9 in cells lacking both caspase-3 and -7 (Fig. 4B). Similarly, 
decreased apical caspase activation could be detected in the 658w and 
Jurkat cell lines following treatment with Bir/TNF (Fig. 4C). We also 
observed that caspase-3/7 knockout cells show no apparent cleavage 
of Bid, a well-known direct substrate of caspase-8 (Fig. 4, A and B) 
(27). Similarly, fluorogenic caspase-8 and -9 substrates revealed a lack 
of apical caspase activity in caspase-3/7–deficient cells following 
treatment with Bir/TNF (Fig. 4, D to G). Overall, these results point to 
the unexpected conclusion that full activation of both the initiator and 
effector caspases is dependent on the presence of effector caspases 
within leukemia cell lines.
To pursue this conclusion, we next performed similar experiments 
to examine the activation of activator caspases following stimulation 
with the intrinsic apoptotic inducer ABT263 in caspase-3/7–deficicent 
cells. In this case, treatment of casp3/7−/− NALM6 cells also resulted in 
lower and delayed cleavage of caspase-8 and -9 (Fig. 5A) and markedly 
decreased caspase cleavage of fluorogenic caspase substrates (Fig. 5, 
B to E).
Together, these results support a model wherein either caspase-3 
or -7 can provide essential feedback signaling upon apical caspases, 
driving cells to full apoptotic cell death.
Caspase-3 or -7 activity is required for mitochondrial 
depolarization and cytochrome c release
We lastly wished to investigate a canonical upstream marker of apop-
tosis within caspase-3/7–deficient cells, mitochondrial outer mem-
brane permeabilization. As measured by TMRE staining and flow 
cytometry, treatment of WT NALM6 cells with ABT263 results in a 
complete loss of mitochondrial membrane potential within 24 hours, 
whereas caspase-3/7 knockout cells remained mostly TMREhigh (Fig. 6, 
A and B). Casp-3/7−/− cells did exhibit a consistent partial loss of 
TMRE signal at 24 hours after treatment with ABT263.
Similar to our earlier observations of the lock-step activation of 
both intrinsic and extrinsic apoptotic caspases, mitochondrial de-
polarization occurred in WT NALM6 cells following treatment with 
the extrinsic apoptotic stimulus Bir/TNF (Fig. 6, C and D). Similar 
to intrinsic stimulation with ABT263, we only observed a partially 
depolarized phenotype in caspase-3/7–deficient cells following treat-
 ment with Bir/TNF (Fig. 6, C and D).
To functionally demonstrate the feedback control effect of 
caspase-3 and -7 on mitochondrial membrane integrity, we also 
analyzed cytochrome c release upon intrinsic apoptosis activation 
in WT and casp-3/7−/− cells. As anticipated on the basis of on our 
TMRE analyses, leukemic cells deficient for caspase-3 and -7 showed a 
marked decrease in cytochrome c release compared to WT controls 
upon treatment with ABT263 (Fig. 6, E and F). These results indi-
cate that, in the absence of caspase-3 and -7, intrinsic or extrinsic 
apoptotic stimuli do indeed result in a shift in mitochondrial polar-
ization and limited release of cytochrome c, but a new stable mito-
chondrial membrane state can be reached in the absence of feedback 
signaling provided by effector caspases.
DISCUSSION
As a process, apoptosis integrates a multitude of pro– and anti–cell 
death signals to a single decision for life or death. This type of “all-
or-none” response to quantitative inputs is common in biological 
phenomena such as cell proliferation and differentiation and is often 
associated with a network topology containing positive feedback loops 
(28). While the ability of caspases to self-cleave provides one level of 
such feedback activity (17), we find that this feedback extends to 
cross activation between both the extrinsic and intrinsic pathways, 
with specific activation of either extrinsic or intrinsic apoptosis lead-
ing to near simultaneous activation of both caspase-8 and -9 in all 
apoptotic cells tested in this experiment. This supports a model where-
in, although initiation of caspases is segregated by distinct pathways, 
an apoptotic signal, once having reached a threshold level, leads to a 
simultaneous activation across both arms of the apoptotic network. 
Several signaling mechanisms connecting intrinsic and extrinsic apop-
totic pathways have been previously identified such as Bid cleavage 
by caspase-8, which can lead to intrinsic mitochondrial apoptotic 
signaling (29), and the secondary mitochondrial activator of caspases 
that blocks cIAP function to greatly increase extrinsic apoptotic death 
receptor signaling (30, 31). Nonetheless, we find it curious that in 
those cells tested here, caspase-8 and -9 activation occurs consistently 
in complete lock step, and we would question whether detectable 
caspase-8 or -9 activation within cells is more often a function of 
feedback activation rather than primary induction by specific intrinsic 
or extrinsic mechanisms.
The timing of caspase-8 and -9 activation was also coordinated 
with progressive conversion of effector caspase-3, -7, and -6 from 
their pro to active forms. The specific role of these individual effec-
tor caspases in apoptosis has thus far remained unclear; in particular, 
the individual functional contribution of different effector caspases 
has not been investigated within the context of living human cells. 
Although previous evidence has suggested redundant function be-
tween caspase-3 and -7 in knockout healthy mice (16), we still ques-
tioned whether these enzymes would function in an additive and/or 
redundant capacity and what the dosage effects of single loss of effector 
caspases would be in a human and disease context. CRISPR-mediated 
gene editing, which enables precision inactivation of single or multiple 
genes simultaneously, allows us to address this point in human can-
cerous cells. We find here that complete removal of either caspase-3, -7, 
or -6 resulted in no significant difference in response to specific in-
ducers of extrinsic and intrinsic apoptosis. These results indicate that 
the dose of effector caspase expression may be at least somewhat irrel-
evant to the apoptotic decision, and the presence of either caspase-3 
or -7 is adequate to fulfill their role in apoptotic cell death within 
human leukemic cell lines. Our protein expression analysis also did 
not indicate compensatory increases in caspase expression when 
a single-effector caspase was genetically deleted.
In contrast to our observations with single-knockout cell lines, 
leukemic cells deficient in both caspase-3 and -7 showed profound 
resistance to both extrinsic and intrinsic apoptotic stimuli. While dif-
ferences in the substrate targets of caspase-3 and -7 could hypotheti-
cally result in differential apoptotic activation under some contexts, 
we find that, in response to acute apoptotic stimulation of human 
leukemic cells, either caspase-3 or -7 is adequate for robust apoptotic 
cell death. Consistent with previous observations (32), loss of 
caspase-6 expression seemed to be irrelevant to apoptosis in this 
context. Caspase-3 and -7 are found on separate chromosomes in 
the human genome, whereas caspase-6 is found on the same arm of 
chromosome 4 as caspase-3; this could perhaps point to evolutionary 
pressure to genomically segregate redundant and essential caspase 
genes and may further explain why complete loss of effector caspases 
is rarely seen in cancer cells.
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Fig. 4. Simultaneous absence of caspase-3 and -7 results in a significant decrease in caspase-8 and -9 activation in extrinsic apoptosis. (A to C) Western blot of 
NALM6 wild-type (WT) and caspase-3, -7, and -6−/− cells as well as caspase-3/7−/− or caspase-3/7/6−/− cells untreated or treated with Birinapant (50 nM) and hTNF (10 ng/ml) 
for the indicated times. Cells were lysed and processed for Western blot. (A) Disrupting a single effector caspase-3, -7, or -6 results in no difference in caspase-8 or -9 acti-
vation. Incubation with caspase-8 antibody shows appearance of intermediate cleaved caspase-8 (41/43 kDa) and active caspase-8 (18 kDa) in WT cells and in caspase-3, -7, 
or -6−/−. Incubation with caspase-9 antibody shows appearance of cleaved caspase-9 (37/35 kDa) in WT cells and in caspase-3, -7, or -6−/−. Line graphs show the mean ± 
SEM for two repeated experiments performed in duplicate. (B) Disruption of caspase-3 and -7 simultaneously results in significant delay of the appearance of intermediate 
cleaved caspase-8 and no appearance of active caspase-8 as well as significant reduction and delay of cleaved caspase-9. Similar results in caspase-3/7/6−/−. (C) Jurkat WT 
and caspase-3/7−/− cells as well as 658w WT and caspase-3/7−/− cells show analog results. (D to G) NALM6 WT or caspase-3/7−/− cells were left untreated or treated for 
22 hours with Birinapant (50 nM) and hTNF (10 ng/ml). Treated WT NALM6 cells show increased cleavage of caspase-8 (E) and caspase-9 (G) substrates over indicated time, 
whereas caspase-3/7−/− show no increased activity for caspase-8 and -9 substrates. Quantitation of caspase-8 and -9 activity is given (E and G), respectively. Histograms 
show representative data from at least two experiments performed in duplicate, with the mean from these ± SEM presented in the line graphs.
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Upon apoptotic stimulation of our caspase-3/7 double-knockout 
cell lines, we also observed a strong decrease in apical caspase-8 
and -9 activation. This adds to a growing body of evidence to indicate 
that effector caspase feedback increases apical caspase activation. 
Cell-free systems have shown significantly reduced caspase-9 cleavage 
in the absence of caspase-3 (18, 33), although caspase-8 seems to be 
less sensitive to a caspase-3 activity in a similar system (13). Direct 
cleavage of upstream caspases by caspase-3 or 7 does not only necessarily 
result in activation, particularly in the context of caspase-9 but also 
involves general disinhibition of caspases through effector caspase- 
mediated cleavage of the endogenous caspase inhibitor XIAP (12, 34, 35). 
Whether through direct cleavage or indirectly through deactivation 
of inhibitory molecules, the data presented here clearly demonstrate 
that caspase-3 and -7 act as essential and redundant signal amplifiers 
of both apoptotic programs within intact leukemia cells. This corrob-
orates earlier data in normal hematopoiesis obtained in mice (36), 
where deletion of caspase-3 and -7 results in some defects in the he-
matopoietic system (16, 37) and where absence of caspase-9 leads to 
severely affected hematopoietic stem cell function (38, 39) and 
confers resistance to infection by RNA and DNA viruses (40).
Mitochondrial outer membrane permeabilization is a microcosm 
of the larger apoptotic program, in that it directly disrupts the cellu-
lar process of mitochondrial energy production while also providing a 
signal to increase apoptotic signaling through release of cytochrome c 
(41). In the absence of caspase-9 or -3/7 expression, we observed that 
cells were able to maintain mitochondrial membrane potential and 
show limited cytochrome c release after treatment with direct inhibitors 
of BCL2. Similar results were previously shown using caspase-3/7 
double-knockout mouse embryonic fibroblasts (16). Similar to previous 
observations (42), we also saw a consistent decrease in mitochondrial 
polarization following apoptotic induction in caspase-3/7–deficient 
cells, suggesting that in the absence of effector caspase feedback, 
caspase-9 and BCL2 family proteins will reach a new equilibrium 
state without triggering full depolarization. Similarly, partial cyto-
plasmic cytochrome c following ABT263 treatment has also been 
observed in caspase-9–deficient cells (22). Such feedback control of 
mitochondrial activity will have to be taken into account when inter-
preting BH3 profiling results and apoptotic dependencies (43). These 
data support a model wherein feedback regulation lies at the heart of 
the apoptotic program, wherein caspase-9 and casp-3/7–dependent 
cleavage of antiapoptotic BCL2 family members enhances mitochon-
drial depolarization and release of cytochrome c (15, 23, 24).
Here, we have provided a systematic deconstruction of the caspase 
network in human leukemic cell lines. We show how caspase-3 and -7 
specifically function as a redundant central node in this network, with-
out which cells fail to fully activate upstream elements of the apoptotic 
process. Ultimately, it is these interconnected feedback loops that 
integrate pro- and antiapoptotic signals into the all-or-none apoptotic 
switch and regulate the cellular response to perturbations of cellular 
homeostasis (Fig. 6G). Thus, effector caspase-3 and -7 are crucial and 
redundant amplifiers of the apoptotic signal, where the presence 
of either one is sufficient for full activation of both upstream and 
A B C
D E
Fig. 5. Simultaneous absence of caspase-3 and -7 is required for significant decrease of caspase-8 and -9 activation in intrinsic apoptosis. (A) NALM6 WT or 
caspase-3/7−/− cells were left untreated or treated for the indicated time with ABT263 5 M. Cells were lysed and processed for Western blot. (B to E) NALM6 WT or 
caspase-3/7−/− cells were left untreated or treated 22 hours with ABT263 at a concentration of 5 M. WT NALM6 cells treated with ABT263 show metabolic activity 
for caspase-8 (B and C) and caspase-9 (D and E) substrates. Caspase-3/7−/− cells show no increased metabolic activity for caspase-8 (B and C) and caspase-9 (D and E) 
compared to untreated cells. Quantitation of caspase-8 and -9 activity, respectively. Histograms show representative data from at least two independent experiments 
performed in duplicate, with the mean from these ± SEM presented in the line graphs.
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downstream mechanisms of the apoptotic program. Overall, these 
results extend a significant body of work identifying feedback 
mechanisms within the apoptotic program, primarily conducted 
in mouse cells, frequently also using nonspecific chemical inhibi-
tors, and/or in acellular systems. Bringing this into living human 
cells, our data place caspase-3 and -7 at the center of a fundamen-
tally recursive apoptotic program, where these enzymes act as 
redundant signal amplifiers, essential for activation of both up-
stream and downstream apoptotic processes and efficient cell 
death.
MATERIALS AND METHODS
LC knockout of caspases
Single and multigene knockouts were generated using the multicolor 
LC system, which we have previously described (21). Briefly, sgRNA 
sequences were cloned into multicolor LC vectors via one-pot restriction- 
ligation reaction using Esp3I restriction enzyme (catalog no. ER0451; 
Thermo Fisher Scientific). Various sgRNA sequences were tested 
to identify specific sequences that produced a consistent knockout 
as examined via Western blot. The following sgRNA sequences, in-
cluding PAM (protospacer adjacent motif), were chosen for CRISPR 
A B
C D
E
G
F
Fig. 6. Caspase-3– and -7–deficient cells maintain mitochondrial membrane polarity following intrinsic or extrinsic apoptotic stimuli. (A) TMRE staining and 
(B) quantification of mean TMRE signal in NALM6 WT and caspase-3/7 knockout cells treated with ABT263 (5 M) for the indicated time points. TMRE flow cytometry 
measurements (A and C) and quantification plot (B and D) of NALM6 WT and caspase-3/7 knockout cells treated with Birinapant (50 nM) and TNF (10 ng/ml) for the indi-
cated time points. Cytochrome c release measurement by flow cytometry (E) and its corresponding quantification graph (F) of NALM6 WT and caspase-3/7 knockout cells 
untreated (control) or treated with ABT263 (5 M). Flow cytometry graphs are representative images of three independent experiments. Quantification graphs show the 
mean from three independent experiments ± SEM. (G) Graphical model of feedback activation by caspase-3 and -7 upon apoptotic stimulation. Histograms show repre-
sentative data from at least three independent experiments performed in duplicate, with the mean from these ± SEM presented in the line or bar graphs.
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targeting: caspase-3, GGAAGCGAATCAATGGACTCTGG; caspase-7, 
GAAGCACTTGAAGAGCGCCTCGG; caspase-6, AAGATTGT-
CTCTATCTGCGCAGG; caspase-8, TGATC GACCCTCCGCCAG-
AAAGG; caspase-9, GTTCAGGCCCCA TATGATCGAGG. Target 
cells were then transduced with specific LC vectors at a multiplicity 
of infection of ~0.1 and single cell–sorted to produce single- or multi- 
knockout cell lines as desired. Single-cell clones were screened via 
Western blotting for desired gene knockouts.
Cell culture
Cell lines used in this study include standard human T cell leukemia 
(Jurkat), human B cell leukemia (NALM6) cell lines, and a patient- 
derived B cell leukemia cell line that we have previously reported 
[658w, (21)]. All cell lines were cultured in RPMI 1640 medium 
(catalog no. R0883; Sigma-Aldrich) supplemented with 10% fetal 
bovine serum (Sigma-Aldrich), 0.5% l-glutamine (BioConcept), 
and 0.5% penicillin/streptomycin (Life Technologies) and incubated 
at 37° until colonies reached a population size of about 5 × 105 cells/ml. 
Cells were passaged every 3 days by dilution of the cells to a concen-
tration of around 1 × 105 cells/ml.
Western blot
Cells were harvested and lysed using SDS lysis buffer [62.5 nM tris 
(pH 6.8), 1% SDS, 0.005% bromophenol blue, 4% glycerol, and 1% 
(v/v) ß-mercaptoethanol]. Samples were then vortexed and incubated 
at 95° for 5 min. Lysates were normalized to cell number and subjected 
to SDS polyacrylamide gel electrophoresis, transferred to nitrocellulose 
membranes, and blocked with buffer consisting of TBS (tris-buffered 
saline)–T with 5% fat-free milk powder. The membranes were then 
incubated with primary antibodies against caspase-3, -7, -6, -8, or -9 
(catalog nos. 9662S, 9492S, 9762S, 9746S, or 9502S, respectively; Cell 
Signaling), cIAP (catalog no. 3130; Cell Signaling), Bid (catalog no. 
2002S; Cell Signaling), or tubulin (catalog no. 081 M4861, 1:1000; Sigma- 
Aldrich). After washing the membranes with TBS-T at room tempera-
ture, we then added the secondary antibodies (1:5000) EasyBlot 
anti-rabbit or anti-mouse (catalog nos. GTX221666-01 and GTX221667-
01, respectively; GeneTex). The reactive bands were visualized by 
chemiluminescence and captured using Imager Lab.
Cell viability
To quantify the number of living cells, we used Cell Counting Kit-8 
(catalog no. CK04-11, 1:10; Dojindo Molecular Technologies), con-
taining WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-
5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt]. WST-8 was 
bioreduced by cellular dehydrogenases to an orange-colored dye 
that is soluble in tissue culture medium and is directly proportional 
to the number of living cells. Suspension was incubated for 1 hour at 
37°. Viability was quantified by measuring the absorbance of color 
(450 nm) at the spectrophotometer and normalizing the data to the 
untreated cells. We also measured cell viability and membrane in-
tegrity with 7-AAD viability staining solution (catalog no. 559925; 
BD Pharmingen). Briefly, cell pellet was resuspended in 0.5 ml of 
cell staining buffer, and then 5 l of 7-AAD per million cells was added 
and incubated for 5 to 10 min in the dark before flow cytometry 
analysis.
Fluorogenic substrates
Caspase-3/7 as well as caspase-8 and -9 activity was measured using 
flow cytometry. Briefly, cells were cultured and plated in a concentration 
of 200,000 cells/ml. We then treated the cells either with ABT263 
(5 M) (intrinsic apoptotic stimulus) or Birinapant (50 nM) and hTNF 
(10 ng/ml) (B + T) (extrinsic apoptotic stimulus) for 1 to 30 hours. 
The cell suspension was centrifugated and resuspended in RPMI 
1640 to stop the reaction. Using FAM-FLICA Caspase Assay Kit 
for caspase-8 (catalog no. 910; ImmunoChemistry Technologies), for 
caspase-9 (catalog no. 912; ImmunoChemistry Technologies), and for 
caspase-3/7 (catalog no. 93; ImmunoChemistry Technologies), we 
incubated the cells in 1:30 of 1:5-diluted FLICA staining buffer for 
30 min protected from light. Fluorescence was detected by flow 
cytometry (FAM-FLICA excites at 492 nm and emits at 520 nm).
Measuring mitochondrial depolarization
For the detection of mitochondrial membrane potential changes, 
NALM6 WT and caspase-3/7−/− cells were plated on a 96-well plate, 
30,000 cells/100 l per well. Cells were then treated with 5 M ABT263 
and 50 nM Birinapant with hTNF (10 ng/ml) for 4, 18, and 24 hours. 
Cells were stained with 50 nM tetramethylrhodamine ethyl-esther 
(catalog no. 87917; Sigma-Aldrich) for 5 to 20 min, incubated at 37°C 
and 0.5% CO2, and shielded from light. Then, they were transferred 
to fluorescence-activated cell sorting tubes and diluted to 300 l 
with 1× phosphate-buffered saline (PBS) and analyzed with flow 
cytometry.
Cytochrome c release
Cytochrome c release was assessed as previously described (44). Cells 
were incubated in 1:200 mouse anti–cytochrome c antibody 
(catalog no. 556432; BD Pharmingen) and 1:200 PE Rat anti-mouse 
IgG1 (immunoglobulin G1) secondary antibody (catalog no. 550083; 
BD Pharmingen).
Drugs and chemicals
Recombinant human TNF was purchased from Gibco/Life Technol-
ogies (catalog no. PHC3011). TNF-neutralizing antibody was pur-
chased from Cell Signaling (catalog no. 7321). Birinapant was 
purchased from Selleckchem (catalog no. S7015). ABT263 (Navitoclax) 
was purchased from Selleckchem (catalog no. S1001). Z-VAD-FMK 
was purchased from ApexBio (catalog no. A1902). Necrostatin-1 was 
purchased from BioVision (catalog no. 2263-1). FasL was purchased 
from Enzo Life Sciences (catalog no. ALX-522-001-C010).
Colony-forming unit assay
Nalm6, Jurkat, and 658w WT and casp-3/7−/− cells were plated in 
3 ml of RPMI 1640 complete medium in six-well plates at a concen-
tration of 2 × 105 cells per well. The cells were then treated for 
24 to 48 hours with either Birinapant (50 nM) and TNF (10 ng/ml), 
ABT263 (5 mM), or vehicle. The cells were then collected, washed 
with PBS, mixed with Methocult Optimum media (catalog no. 4034; 
StemCell Technologies), and plated at a concentration of 1000 cells 
per well in six-well SmartDish plates (catalog no. 27370; StemCell 
Technologies). Cells were aliquoted in duplicate samples. After 
10 to 14 days, colony- forming units were visually counted under a 
microscope.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/7/eaau9433/DC1
Fig. S1. Caspase-8 and -9 are specifically required to activate extrinsic and intrinsic apoptosis, 
respectively.
Fig. S2. Caspase-3 and -7 have overlapping roles in executing apoptotic cell death.
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